Chemical activators of MAGE family member A9 employ various mechanisms to influence the activation of this protein. Resveratrol, by activating the sirtuin pathway, can lead to the enhancement of cellular stress responses, which in turn can increase the stability or interaction of MAGE family member A9 with other regulatory proteins. Trichostatin A and sodium butyrate, both histone deacetylase (HDAC) inhibitors, can lead to a more open chromatin structure around the MAGE family member A9 genomic locus. This relaxed chromatin can facilitate post-translational modifications necessary for the protein's activation. Similarly, SAHA (Vorinostat) and phenylbutyrate, also HDAC inhibitors, promote acetylation of histones, potentially enhancing the protein's activation by facilitating the binding of transcription factors or other proteins that assist in its post-translational activation.
On the other hand, 5-Azacytidine and epigallocatechin gallate (EGCG) both inhibit DNA methyltransferases, which can activate MAGE family member A9 by decreasing the methylation levels of DNA around its regulatory regions, thereby improving the transcriptional accessibility. Disulfiram's interaction with copper, leading to proteasome inhibition, can result in reduced degradation of MAGE family member A9, allowing for its accumulation and activation within the cell. SRT1720, as an activator of SIRT1, can enhance the protein's activation through the optimization of cellular stress responses. Parthenolide's inhibition of NF-κB can result in upregulation of alternative stress response pathways that may include MAGE family member A9 activation. Sulforaphane and dimethyl fumarate both activate the Nrf2 pathway, which can lead to the activation of MAGE family member A9 as part of the cellular defense mechanism to oxidative stress, potentially increasing its stability or facilitating interactions with co-activator proteins. These diverse chemical interactions converge to promote the activation state of MAGE family member A9.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates the sirtuin pathway, which in turn can lead to the activation of MAGE family member A9 by enhancing the cellular stress response and potentially increasing the protein's stability or interaction with other regulatory proteins that stabilize its active form. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases (HDACs), which can result in a more relaxed chromatin structure around the MAGE family member A9, thereby promoting its activation by facilitating post-translational modifications that are required for its activation. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine inhibits DNA methyltransferases, leading to reduced methylation of DNA. This demethylation can activate MAGE family member A9 by improving the transcriptional accessibility of its regulatory regions, allowing for enhanced protein-protein interactions necessary for its activation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate functions as a HDAC inhibitor, promoting acetylation of histones around the MAGE family member A9 locus, which could enhance the protein's activation by facilitating the binding of transcription factors that assist in its post-translational activation. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $53.00 $89.00 | 7 | |
Disulfiram can chelate copper, forming a complex that inhibits the proteasome. This inhibition may lead to reduced degradation of MAGE family member A9, thereby increasing its activation by accumulation in the cell. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
SAHA, another HDAC inhibitor, can enhance acetylation of histones at the MAGE family member A9 locus, promoting activation by allowing for a more accessible chromatin configuration that facilitates its functional interactions. | ||||||
Sodium phenylbutyrate | 1716-12-7 | sc-200652 sc-200652A sc-200652B sc-200652C sc-200652D | 1 g 10 g 100 g 1 kg 10 kg | $77.00 $166.00 $622.00 $5004.00 $32783.00 | 43 | |
Phenylbutyrate is an HDAC inhibitor that can activate MAGE family member A9 by promoting a chromatin environment conducive to its activation through increased acetylation of histones surrounding its gene locus. | ||||||
SRT1720 | 1001645-58-4 | sc-364624 sc-364624A | 5 mg 10 mg | $197.00 $364.00 | 13 | |
SRT1720 is an activator of SIRT1, a sirtuin that can deacetylate proteins and influence longevity and metabolism. Activation of SIRT1 can lead to activation of MAGE family member A9 by optimizing cellular stress responses and potentially facilitating its active conformation or stabilization. | ||||||
Parthenolide | 20554-84-1 | sc-3523 sc-3523A | 50 mg 250 mg | $81.00 $306.00 | 32 | |
Parthenolide inhibits NF-κB, a factor involved in cellular stress responses. Inhibition of NF-κB can cause a compensatory upregulation of other stress response pathways that may include the activation of MAGE family member A9 through alternative stress-responsive signaling mechanisms. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG can inhibit DNA methyltransferases, which may lead to hypomethylation of the MAGE family member A9 locus and promote activation by increasing the transcriptional accessibility and subsequent translation into the active protein. | ||||||